Abstract
The main challenge of immunosuppressive therapy after solid organ transplantation is to create a new immunological balance that prevents organ rejection and does not promote opportunistic infection. Torque teno virus (TTV) a ubiquitous and non-pathogenic single-stranded DNA virus has been proposed as a marker of functional immunity in immunocompromised patients. Here investigate whether TTV loads predict the risk of common viral infection and allograft rejection in kidney transplantation recipients.
In a retrospective cohort of 389 kidney transplantation recipients, individual TTV loads in were measured by qPCR in consecutive plasma samples during one year follow-up. The endpoints were allograft rejection, BK polyomavirus (BKPyV) viremia and cytomegalovirus (CMV) viremia. Repeated TTV measurements and rejection and infection survival data were analysed in a joint model.
During follow-up, TTV DNA detection in the transplant recipients increased from 85 to 100%. The median viral load increased to 107 genome copies/ml within three months after transplantation. Rejection, BKPyV viremia and CMV viremia occurred in 23%, 27% and 17% of the patients, respectively. With every 10-fold TTV load-increase, the risk of rejection decreased considerably (HR: 0.74, CI 95%: 0.71-0.76), while the risk of BKPyV and CMV viremia remained the same (HR: 1.03, CI 95%: 1.03-1.04 and HR: 1.01, CI 95%: 1.01-1.01).
In conclusion, TTV load kinetics predict allograft rejection in kidney transplantation recipients, but not the BKPyV and CMV infection. The potential use of TTV load levels as a guide for optimal immunosuppressive drug dosage to prevent allograft rejection deserves further validation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was supported in part by the Dutch Kidney Foundation, grant 13A1D302, and by an Excellent Student grant for Aline van Rijn by the Leiden University Medical Center.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol was approved by the local scientific committee and submitted to the medical ethics committee of the LUMC, who declared no objection.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Authorship AvR, JR, HW and MF designed cohort and the study. CdB performed the laboratory measurements. The biostatistical analysis was planned by IS and HP, and performed by AvR. AK, JR and MF provided resources. HW, IS, CdB and AdV provided critical feedback on the manuscript written by AvR under supervision of JI and MF.
Disclosure The authors declare no conflicts of interest.
Funding This study was supported in part by the Dutch Kidney Foundation, grant 13A1D302, and by an Excellent Student grant for Aline van Rijn by the Leiden University Medical Center.
Data Availability
The data that support the findings of this study are available on request from the corresponding author, AvR. The data are not publicly available due to privacy and ethical reasons.
Abbreviations
- BKPyV
- BKpolyomavirus
- CI
- Confidence interval
- CNI
- Calcineurin inhibitor
- ESDR
- End stage renal disease
- HR
- Hazard ratio
- IQR
- Inter quartile range
- KTx
- Kidney transplantation
- LOD
- Limit of detection
- LUMC
- Leiden University Medical Center
- PCR
- Quantitative PCR
- SOTx
- Solid organ transplantation
- t
- time
- TTV
- Torque teno virus
